癌症相关显著突变基因的遗传变异与肺癌易感性
基于癌症基因组图谱(TCGA)识别的127个显著突变基因(SMG),在大规模病例对照研究中系统评价1655个标签单核苷酸多态性(SNP)与肺癌风险的关联,发现11个SNP与风险一致相关,8个SNP在发现和验证阶段均显著相关;PPP2R1A的rs10412613关联最强,次要G等位基因与肺癌风险降低相关(OR=0.91,95%CI 0.87-0.96,P=2.3×10-4)。
要点
- PPP2R1A的rs10412613次要G等位基因与肺癌风险降低相关(OR=0.91,95%CI 0.87-0.96)。
- 由11个SNP加权构建的风险评分随评分升高,肺癌风险持续升高(趋势P=9.5×10-9)。
- rs10412613、rs10804682、rs635469和rs6742399分别与PPP2R1A、ATR、SETBP1和ERBB4表达显著相关。
核心结论
- 研究揭示了SMG中与肺癌风险相关的新遗传变异,可能有助于阐明肺癌发生发展的生物学网络。
研究设计与样本
- 研究为大规模病例对照研究,系统评价127个由TCGA识别的SMG中1655个标签SNP与肺癌风险的关联,并分析验证SNP的功能效应、基因突变频率和通路。
主要发现
- 发现8个基因中的11个SNP呈一致关联(P<0.1),8个SNP在发现和验证阶段均与肺癌风险显著相关(P<0.05);关联最强的是PPP2R1A的rs10412613(OR=0.91,95%CI 0.87-0.96,P=2.3×10-4),次要G等位基因与肺癌风险降低相关。
- 风险评分累积分析显示风险随评分升高而持续升高(趋势P=9.5×10-9);分层分析中PPP2R1A:rs10412613与肺癌风险的关联在诊断时较年轻人群和从不吸烟者中似乎更强。
- 表达数量性状位点分析显示rs10412613、rs10804682、rs635469和rs6742399基因型分别与PPP2R1A、ATR、SETBP1和ERBB4表达显著相关;TCGA数据显示这些基因在肺癌组织与正常组织中的表达显著不同,且这些基因的最高突变频率见于肺癌;整合通路分析提示这些基因主要参与AKT/NF-κB调控通路。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer initiation and development are driven by key mutations in driver genes. Applying high-throughput sequencing technologies and bioinformatic analyses, The Cancer Genome Atlas (TCGA) project has identified panels of somatic mutations that contributed to the etiology of various cancers. However, there are few studies investigating the germline genetic variations in these significantly mutated genes (SMGs) and lung cancer susceptibility. PATIENTS AND METHODS: We comprehensively evaluated 1655 tagged single nucleotide polymorphisms (SNPs) located in 127 SMGs identified by TCGA, and test their association with lung cancer risk in large-scale case-control study. Functional effect of the validated SNPs, gene mutation frequency and pathways were analyzed. RESULTS: We found 11 SNPs in 8 genes showed consistent association (P < 0.1) and 8 SNPs significantly associated with lung cancer risk (P < 0.05) in both discovery and validation phases. The most significant association was rs10412613 in PPP2R1A, with the minor G allele associated with a decreased risk of lung cancer [odds ratio = 0.91, 95% confidence interval (CI): 0.87-0.96, P = 2.3 × 10-4]. Cumulative analysis of risk score built as a weight sum of the 11 SNPs showed consistently elevated risk with increasing risk score (P for trend = 9.5 × 10-9). In stratified analyses, the association of PPP2R1A:rs10412613 and lung cancer risk appeared stronger among population of younger age at diagnosis and never smokers. The expression quantitative trait loci analysis indicated that rs10412613, rs10804682, rs635469 and rs6742399 genotypes significantly correlated with the expression of PPP2R1A, ATR, SETBP1 and ERBB4, respectively. From TCGA data, expression of the identified genes was significantly different in lung tumors compared with normal tissues, and the genes' highest mutation frequency was found in lung cancers. Integrative pathway analysis indicated the identified genes were mainly involved in AKT/NF-κB regulatory pathway suggesting the underlying biological processes. CONCLUSION: This study revealed novel genetic variants in SMGs associated with lung cancer risk, which might contribute to elucidating the biological network involved in lung cancer development.
引用
- Zhang Y, Zhang L, Li R, et al. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility. Ann Oncol. 2017. PMID: 28383694. doi:10.1093/annonc/mdx161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。